Recombinant Human Neurocan Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 6508-NC
Key Product Details
Product Specifications
Source
Chinese Hamster Ovary cell line, CHO-derived human Neurocan protein
Glu23-Cys1321, with a C-terminal 6-His tag
Glu23-Cys1321, with a C-terminal 6-His tag
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Glu23
Predicted Molecular Mass
141.5 kDa
SDS-PAGE
140-290 kDa, reducing conditions
Activity
Measured by the ability of the immobilized protein to enhance the adhesion of H4 human neuroglioma cells.
When 5 x 104 cells per well are added to recombinant human Neurocan coated plates, cell adhesion is enhanced in a dose dependent manner. The ED50 for this effect is 50-200 ng/mL.
When 5 x 104 cells per well are added to recombinant human Neurocan coated plates, cell adhesion is enhanced in a dose dependent manner. The ED50 for this effect is 50-200 ng/mL.
Formulation, Preparation and Storage
6508-NC
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Neurocan
C-terminal (Neurocan-C) fragments whose core glycoproteins are 130 kDa and 150 kDa, respectively (4, 5). The full length molecule is expressed in the developing and juvenile brain, while its cleavage products are found throughout adulthood (3, 4). Neurocan and Neurocan-C are produced by astrocytes and accumulate in the matrix surrounding axonal bundles and neuronal cell bodies; Neurocan-130 is found mainly in the glial cell cytoplasm (6 - 8). Following brain injury, reactive astrocytes deposit increased amounts of Neurocan in the glial scar where it impedes axonal regeneration (6, 9). Neurocan inhibits neuronal adhesion and neurite outgrowth through interactions with a variety of matrix and transmembrane molecules including NCAM-L1, NCAM-1, Syndecan-3, Glypican-1, Tenascin, Contactin-2/TAG1, and HAPLN1 (1, 6, 10 - 15).
References
- Rauch, U. et al. (2001) Cell. Mol. Life Sci. 58:1842.
- Prange, C.K. et al. (1998) Gene 221:199.
- Rauch, U. et al. (1991) J. Biol. Chem. 266:14785.
- Matsui, F. et al. (1994) Neurochem. Int. 25:425.
- Rauch, U. et al. (1992) J. Biol. Chem. 267:19536.
- Asher, R.A. et al. (2000) J. Neurosci. 20:2427.
- Matsui, F. et al. (1998) Brain Res. 790:45.
- Abaskharoun, M. et al. (2010) Brain Res. 1327:6.
- Shen, L.H. et al. (2008) Glia 56:1747.
- Friedlander, D.R. et al. (1994) J. Cell Biol. 125:669.
- Sango, K. et al. (2003) Exp. Neurol. 182:1.
- Akita, K. et al. (2004) Biochem. J. 383:129.
- Grumet, M. et al. (1994) J. Biol. Chem. 269:12142.
- Milev, P. et al. (1996) J. Biol. Chem. 271:15716.
- Rauch, U. et al. (2004) Matrix Biol. 22:629.
Alternate Names
CSPG3, NCAN, NEUR
Gene Symbol
NCAN
UniProt
Additional Neurocan Products
Product Documents for Recombinant Human Neurocan Protein, CF
Product Specific Notices for Recombinant Human Neurocan Protein, CF
For research use only
Loading...
Loading...
Loading...